Methods of determining glucose concentration in whole blood samples
CA 2437249 A1 · Owner: Vreeke, Mark S. · Inventors: Melle, Bryan S.; Genshaw, Marvin A.; Vreeke, Mark S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The glucose concentration in a whole blood sample may be determined by providing, an electrochemical sensor adapted to measure glucose and hematocrit concentrations. The, hematocrit concentration of the whole blood sample is measured using the electrochemical, sensor via electrochemical impedance spectroscopy. The initial glucose concentration of the, whole blood sample is measured using the electrochemical sensor. The unbiased glucose, concentration in the whole blood sample is calculated using the initial glucose concentration, measurement and the hematocrit concentration.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 14, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 14, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 14, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.